Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$24,086,766
-$2,194,329 QoQ
Shares Held
153,693
-10.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
14.63%
of 13F equity value
Holder Rank
#104
of 1,603 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Foresight Global Investors, Inc. holds $58,381,119 across 3 Drug Manufacturers - General names. NVS ranks #1 (41.3% of the industry book) .
All Filings in NVS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,086,766 | 153,693 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $26,281,095 | 172,053 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $23,725,083 | 172,083 | Shares | Sole | 2026-03-19 | |
| 2025-09-30 | $22,016,627 | 171,683 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $19,957,453 | 164,924 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $20,938,731 | 187,825 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $22,611,535 | 232,366 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $25,858,336 | 224,816 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $18,236,172 | 171,296 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $19,092,083 | 197,375 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $13,325,515 | 131,975 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $9,931,350 | 97,500 | Shares | Sole | 2023-10-23 | |
| No filing history on record for this holder in this stock. | ||||||